KP Tissue Inc. (TSE:KPT - Get Free Report) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of C$8.37 and traded as high as C$8.98. KP Tissue shares last traded at C$8.94, with a volume of 8,966 shares.
Wall Street Analyst Weigh In
Several equities research analysts have issued reports on KPT shares. Desjardins lifted their target price on shares of KP Tissue from C$8.50 to C$9.50 and gave the company a "hold" rating in a research report on Thursday, May 22nd. TD Securities lifted their target price on shares of KP Tissue from C$8.00 to C$9.00 and gave the company a "hold" rating in a research report on Thursday, May 22nd. Finally, National Bankshares lifted their target price on shares of KP Tissue from C$8.50 to C$9.50 and gave the company a "sector perform" rating in a research report on Thursday, May 22nd.
Read Our Latest Research Report on KP Tissue
KP Tissue Price Performance
The firm has a market cap of C$89.35 million, a PE ratio of 14.00, a price-to-earnings-growth ratio of -0.88 and a beta of 0.37. The company has a 50 day simple moving average of C$9.03 and a 200-day simple moving average of C$8.37.
KP Tissue Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 15th were paid a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 8.05%. The ex-dividend date of this dividend was Monday, June 30th. KP Tissue's dividend payout ratio is currently 112.73%.
About KP Tissue
(
Get Free Report)
KP Tissue Inc, through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider KP Tissue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KP Tissue wasn't on the list.
While KP Tissue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.